 |
|
Prevention of Herpesvirus Infections in Renal Allograft Recipients by Low-Dose Oral Acyclovir
Linda Seale, MD;
Carol J. Jones, PhD;
Shashi Kathpalia, MD;
George Gee Jackson, MD;
Martin Mozes, MD;
Michael S. Maddux, PharmD;
Donald Packham, MB, BS
JAMA. 1985;254(24):3435-3438.
Abstract
| |
Forty patients with serum antibody against herpes simplex virus (HSV) were enrolled in a randomized, placebo-controlled, double-blind investigation of acyclovir given orally in a low dosage as prophylaxis against recurrent HSV infection after renal transplantation. During 30 postoperative days of medication, 14 of 21 placebo-treated and one of 19 acyclovir-treated patient(s) developed reactivation of HSV infection. Eleven of the former, but not the latter, had herpetic lesions. The protection against active infection with HSV during the period of prophylaxis with acyclovir is statistically highly significant. From 30 to 90 days after transplantation when no antiviral medicine was given, 60% (3/5) of the remaining placebo recipients and 44% (7/16) of the acyclovir patients developed active HSV infections. Herpetic lesions occurred in two of three and two of seven of infected people in the respective groups. No adverse effects of the drug were observed. The results show that HSV infections in immunosuppressed renal allograft recipients can be safely prevented, deferred, and ameliorated by an initial period of prophylaxis with a low dose of oral acyclovir.
(JAMA 1985;254;3435-3438)
Author Affiliations
From the Section of Infectious Diseases, Department of Medicine (Drs Seale, Jones, Kathpalia, Jackson and Packham), and the Division of Transplant Surgery, Departments of Surgery (Dr Mozes) and Pharmacy Practice (Dr Maddux), University of Illinois Hospital, University of Illinois College of Medicine, Chicago.
Footnotes
Reprint requests to PO Box 6998, Chicago, IL 60680 (Dr Jackson).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Herpesvirus Infections in Organ Transplant Recipients
Jenkins et al.
CVI 2003;10:1-7.
FULL TEXT
Heart Transplantation
Bethea et al.
Card Surg Adult 2003;2:1427-1460.
FULL TEXT
Management of herpes virus infections following transplantation
J Antimicrob Chemother 2000;45:729-748.
FULL TEXT
A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy
Stratta et al.
Arch Surg 1992;127:55-64.
ABSTRACT
|
